Dyadic International, Inc. (DYAI)

CIK 0001213809 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 8-K (2026-05-13) · 99.1
FY-2025
Latest FY-2025 8-K (2026-03-25) · 99.1
Q3-2025 8-K (2025-11-12) · 99.1
Q2-2025 8-K (2025-08-13) · 99.1
Q1-2025 8-K (2025-05-14) · 99.1
FY-2024 8-K (2025-03-26) · 99.1
Q3-2024 8-K (2024-11-12) · 99.1
Q2-2024 8-K (2024-08-13) · 99.1
Q1-2024 8-K (2024-05-14) · 99.1
FY-2023 8-K (2024-03-28) · 99.1 · 99.2
Q3-2023 8-K (2023-11-08) · 99.1
Q2-2023 8-K (2023-08-09) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Document and Entity Information
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (current Period Unaudited)
—
Consolidated Balance Sheets (current Period Unaudited) (P)
—
Consolidated Balance Sheets (P)
Consolidated Statements of Operations
Consolidated Statements of Stockholders' Equity
Consolidated Statements of Cash Flows
Consolidated Statements of Stockholders' Equity (P)
Consolidated Statements of Cash Flows (unaudited) (P)
—
Notes
Cash, Cash Equivalents, and Investments
—
Cash, Cash Equivalents, Restricted Cash and Short-term Investments
—
Commitments and Contingencies
Convertible Notes
—
Convertible Notes Payable
—
Cybersecurity Risk Management and Strategy Disclosure
—
Income Taxes
—
Insider Trading Arrangements
Note 1
Note 10
—
Note 2
Note 3
Note 4
Note 5
Note 6
Note 7
Note 8
Note 9
Organization and Summary of Significant Accounting Policies
Pay Vs Performance Disclosure
Research and Collaboration Agreements, Sublicense Agreements, and Investments In Privately Held Companies
Segment
Share-based Compensation
Shareholders Equity
Subsequent Events